secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001628280-23-037568
Event type: earnings
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience reports Q3 2023 results; no financial details in filing
-----------------------------------------------------------------------

- Press release for Q3 2023 results issued on November 8, 2023.
- No revenue, EPS, or other specific figures are included in this filing text.
- Investors need to review the full press release for complete financial data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000162828023037568/0001628280-23-037568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000162828023037568/aadi-20231108.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-037568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer